| Mar'18 | Mar'17 | Mar'16 | Mar'15 | Mar'14 | Mar'13 | |
|---|---|---|---|---|---|---|
Class A common shares | ||||||
Class C common shares | ||||||
ASSETS | ||||||
Current assets | ||||||
Cash and cash equivalents | ||||||
62,901 | 64,898 | 108,111 | 97,336 | 30,221 | 63,154 | |
Restricted cash | ||||||
- | 392 | 31,836 | 54,417 | 16,007 | - | |
Term deposits | ||||||
- | 4,359 | 12,202 | 14,621 | - | - | |
Accounts receivable, net of allowance for doubtful accounts of $14,261 and $23,142 as of March 31, 2017 and 2018, respectively | ||||||
149,259 | 79,576 | 74,163 | 59,650 | 37,619 | 30,189 | |
Inventories | ||||||
9,261 | 6,781 | 4,015 | 2,661 | 1,693 | 1,162 | |
Deferred tax assets-current | ||||||
- | 9,635 | 8,064 | 5,949 | 3,991 | 2,874 | |
Amount due from related parties | ||||||
7,019 | 4,538 | 4,653 | - | 1,287 | 483 | |
Prepaid expenses and other current assets | ||||||
66,939 | 49,736 | 62,659 | 44,031 | 20,012 | 6,616 | |
Total current assets | ||||||
295,379 | 219,915 | 305,703 | 278,665 | 110,830 | 104,478 | |
Restricted cash-non-current | ||||||
- | - | - | - | 2,153 | - | |
Property and equipment, net | ||||||
173,283 | 163,081 | 130,170 | 105,022 | 63,644 | 32,572 | |
Acquired intangible assets, net | ||||||
21,993 | 25,852 | 37,179 | 30,634 | 17,530 | 4,480 | |
Goodwill | ||||||
117,995 | 107,237 | 108,839 | 72,101 | 41,412 | 17,791 | |
Long-term investments | ||||||
196,816 | 180,758 | 200,108 | 129 | - | - | |
Cost method investment | ||||||
- | - | - | - | 129 | 131 | |
Equity method investment | ||||||
- | - | - | - | 6,220 | - | |
Deferred tax assets-non-current | ||||||
39,380 | 16,698 | 8,077 | 2,212 | 2,007 | 1,456 | |
Rental deposit and other non-current assets | ||||||
20,309 | 14,950 | 13,565 | 10,238 | 6,301 | 4,453 | |
TOTAL ASSETS | ||||||
865,155 | 728,491 | 803,641 | 499,001 | 250,226 | 165,361 | |
LIABILITIES AND EQUITY | ||||||
Current liabilities | ||||||
Accounts payable (including accounts payable of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $34,637 and $43,840 as of March 31, 2017 and 2018, respectively) | ||||||
52,800 | 39,892 | 28,135 | 23,526 | 16,965 | 9,822 | |
Accrued expenses and other current liabilities (including accrued expenses and other current liabilities of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $48,910 and $60,281 as of March 31, 2017 and 2018, respectively) | ||||||
76,586 | 59,278 | 47,404 | 36,790 | 24,275 | 17,191 | |
Income tax payable (including income tax payable of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $6,414 and $13,523 as of March 31, 2017 and 2018, respectively) | ||||||
15,579 | 11,951 | 8,216 | 7,539 | 6,382 | 2,409 | |
Deferred revenues (including deferred revenues of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $57,361 and $87,388 as of March 31, 2017 and 2018, respectively) | ||||||
95,422 | 64,740 | 61,881 | 38,457 | 29,523 | 24,578 | |
Amounts due to related parties (including amounts due to related parties of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of nil and $3,480 as of March 31, 2017 and 2018, respectively) | ||||||
3,692 | - | - | - | 8,049 | 12,379 | |
Short term borrowings (including short term borrowings of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $111,299 and $196,450 as of March 31, 2017 and 2018, respectively) | ||||||
196,450 | 111,299 | 53,364 | - | - | - | |
Deferred government subsidy-current (including deferred government subsidy - current of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $63 and nil of March 31, 2015 and 2016, respectively) | ||||||
- | - | - | 63 | 47 | 63 | |
Short-term borrowings (including short-term borrowings of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $56,772 and $53,364 of March 31, 2015 and 2016, respectively) | ||||||
- | - | - | 56,772 | 18,201 | 5,482 | |
Convertible loan (including convertible loan of the consolidated VIE entities without recourse to iKang Healthcare Group, Inc. of nil and nil of March 31, 2013 and 2014, respectively) | ||||||
- | - | - | - | - | 2,000 | |
Total current liabilities | ||||||
440,529 | 287,160 | 199,000 | 163,147 | 103,442 | 73,924 | |
Long-term borrowings (including long term borrowings of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of 101,697 and $38,884 as of March 31, 2017 and 2018, respectively) | ||||||
38,884 | 101,697 | 229,467 | - | - | - | |
Deferred government subsidy - non-current (including deferred government subsidy-non-current of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc of $63 and nil of March 31, 2014 and 2015, respectively) | ||||||
- | - | - | - | 63 | 125 | |
Long term borrowings (including long term borrowings consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $1,865 and nil of March 31, 2014 and 2015, respectively) | ||||||
- | - | - | - | 1,865 | - | |
Deferred tax liabilities-non-current (including deferred tax liabilities-non-current of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $7,009 and $4,944 as of March 31, 2017 and 2018, respectively) | ||||||
5,917 | 7,229 | 9,772 | 7,506 | 3,478 | 499 | |
TOTAL LIABILITIES | ||||||
485,330 | 396,086 | 438,239 | 170,653 | 108,848 | 74,548 | |
Commitments and contingencies (Note 22) | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Equity | ||||||
iKang Healthcare Group, Inc. shareholders' equity | ||||||
Additional paid-in capital | ||||||
472,677 | 436,649 | 436,746 | 419,862 | 1,342 | 4,341 | |
Statutory reserve | ||||||
18,396 | 14,761 | 11,529 | 8,399 | 5,005 | 2,267 | |
Accumulated deficit | ||||||
-133,642 | -112,698 | -98,215 | - | - | - | |
Accumulated deficit | ||||||
- | - | - | -113,410 | -137,129 | -135,390 | |
Accumulated other comprehensive loss | ||||||
-2,071 | -26,622 | -7,577 | 3,936 | 3,764 | 4,522 | |
Total iKang Healthcare Group, Inc. shareholders' equity | ||||||
355,707 | 312,437 | 342,826 | 319,130 | -126,957 | -124,195 | |
Non-controlling interests | ||||||
24,118 | 19,968 | 22,576 | 9,218 | 3,818 | 1,030 | |
TOTAL EQUITY | ||||||
379,825 | 332,405 | 365,402 | 328,348 | -123,139 | -123,165 | |
TOTAL LIABILITIES AND EQUITY | ||||||
865,155 | 728,491 | 803,641 | 499,001 | 250,226 | 165,361 | |